288 related articles for article (PubMed ID: 20622265)
1. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.
Mallette FA; Calabrese V; Ilangumaran S; Ferbeyre G
Aging (Albany NY); 2010 Jul; 2(7):445-52. PubMed ID: 20622265
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 links cytokine signaling to p53 and senescence.
Calabrese V; Mallette FA; Deschênes-Simard X; Ramanathan S; Gagnon J; Moores A; Ilangumaran S; Ferbeyre G
Mol Cell; 2009 Dec; 36(5):754-67. PubMed ID: 20005840
[TBL] [Abstract][Full Text] [Related]
3. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
4. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
5. Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.
Cooper JC; Shi M; Chueh FY; Venkitachalam S; Yu CL
Int J Oncol; 2010 May; 36(5):1201-8. PubMed ID: 20372794
[TBL] [Abstract][Full Text] [Related]
6. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
7. The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo.
Doggett K; Keating N; Dehkhoda F; Bidgood GM; Meza Guzman LG; Leong E; Kueh A; Nicola NA; Kershaw NJ; Babon JJ; Alexander WS; Nicholson SE
Cytokine; 2023 May; 165():156167. PubMed ID: 36934508
[TBL] [Abstract][Full Text] [Related]
8. SOCS1: phosphorylation, dimerization and tumor suppression.
Lessard F; Saint-Germain E; Mignacca L; Ferbeyre G
Oncoscience; 2019 Nov; 6(11-12):386-389. PubMed ID: 31984217
[TBL] [Abstract][Full Text] [Related]
9. Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling.
Ben-Zvi T; Yayon A; Gertler A; Monsonego-Ornan E
J Cell Sci; 2006 Jan; 119(Pt 2):380-7. PubMed ID: 16410555
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus.
Strebovsky J; Walker P; Lang R; Dalpke AH
FASEB J; 2011 Mar; 25(3):863-74. PubMed ID: 21084693
[TBL] [Abstract][Full Text] [Related]
11. Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.
Fitzgerald JS; Toth B; Jeschke U; Schleussner E; Markert UR
J Reprod Immunol; 2009 Dec; 83(1-2):117-23. PubMed ID: 19853926
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis.
Saint-Germain E; Mignacca L; Huot G; Acevedo M; Moineau-Vallée K; Calabrese V; Bourdeau V; Rowell MC; Ilangumaran S; Lessard F; Ferbeyre G
Cancer Res; 2019 Jul; 79(13):3306-3319. PubMed ID: 31101761
[TBL] [Abstract][Full Text] [Related]
13. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
15. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.
Jegalian AG; Wu H
J Biol Chem; 2002 Jan; 277(3):2345-52. PubMed ID: 11696536
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
[TBL] [Abstract][Full Text] [Related]
18. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
Cooney RN
Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
[TBL] [Abstract][Full Text] [Related]
19. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
20. Suppressors of cytokine signaling abrogate diabetic nephropathy.
Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]